Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | +1.57% |
|
-1.90% | -87.41% |
Jul. 05 | Leerink Upgrades AN2 Therapeutics to Outperform Rating With $5 Price Target | MT |
Jul. 03 | Leerink Partners Upgrades AN2 Therapeutics to Outperform From Market Perform, Price Target is $5 | MT |
Chart calendar AN2 Therapeutics, Inc.
Upcoming events on AN2 Therapeutics, Inc.
Past events on AN2 Therapeutics, Inc.
2024-06-19 11:00 am | Annual General Meeting |
2024-05-14 04:01 pm | Q1 2024 Earnings Release |
2024-03-28 04:10 pm | Q4 2023 Earnings Release |
2024-02-14 10:40 am | Oppenheimer Healthcare Life Sciences Conference |
2023-11-29 08:45 am | Evercore ISI HealthCONx Conference |
2023-11-15 03:00 pm | Stifel Healthcare Conference |
2023-11-09 04:05 pm | Q3 2023 Earnings Release |
2023-10-14 12:15 pm | IDWeek Conference - Poster No :2135 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No :2556 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No :2144 |
2023-10-14 10:54 am | IDWeek Conference - Poster No :2064 |
2023-10-12 08:48 am | IDWeek Conference - Poster No :32 |
2023-08-10 04:10 pm | Q2 2023 Earnings Release |
2023-06-08 04:30 pm | Jefferies Global Healthcare Conference |
2023-06-07 11:00 am | Annual General Meeting |
2023-05-16 02:00 pm | JMP Securities Life Sciences Conference |
2023-05-11 04:10 pm | Q1 2023 Earnings Release |
2023-03-29 04:01 pm | Q4 2022 Earnings Release |
2023-03-14 11:20 am | Oppenheimer Healthcare Conference |
2023-03-07 09:10 am | Cowen Health Care Conference |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -42,3 -41,6 -1.59% | -69,6 -70,9 1.74% | -77,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -64,7 -66,9 3.27% | 0,00 |
Net income Million USD | Released Forecast Spread | -28,1 | -42,8 -43,1 0.67% | -64,7 -67,3 3.79% | -75,6 |
EPS USD | Released Forecast Spread | -25,0 | -2,79 -2,62 -6.35% | -2,74 -2,94 6.8% | -2,43 |
Announcement Date | 04/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -7,68 -9,90 22.39% | -10,3 -11,5 9.76% | -11,8 -11,5 -2.79% | -12,5 -11,9 -5.28% | -16,0 -13,6 -17.93% | -16,6 -16,8 0.89% | -18,2 -16,2 -12.22% | -18,8 -20,1 6.22% | -18,3 -19,4 5.45% | -19,1 | -19,5 | -20,1 | -20,0 | -20,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -19,1 11.48% | |||||||||||||
Net income Million USD | Released Forecast Spread | -9,48 -8,97 -5.67% | -10,1 -10,9 6.87% | -11,3 -11,9 4.45% | -11,8 -12,6 6.02% | -15,3 -13,3 -15.5% | -15,8 -16,7 5.18% | -16,7 -16,2 -3.13% | -16,9 -19,4 13% | -16,6 -18,9 12.23% | -18,6 | -19,6 | -20,7 | -20,0 | -20,0 |
EPS USD | Released Forecast Spread | -2,98 -0,92 -224.8% | -0,53 -1,89 71.91% | -0,59 -0,59 0.56% | -0,61 -0,65 5.67% | -0,79 -0,68 -16.18% | -0,81 -0,85 5.08% | -0,65 -0,63 -3.72% | -0,57 -0,75 23.49% | -0,56 -0,62 9.68% | -0,59 | -0,64 | -0,64 | -0,67 | -0,67 |
Announcement Date | 10/05/22 | 11/08/22 | 09/11/22 | 29/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | 14/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-22 07:00 am | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for AN2 Therapeutics, Inc.
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANTX Stock
- Calendar AN2 Therapeutics, Inc.